{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:27:21Z","timestamp":1791559641545,"version":"4.3.4"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["1R01DK132072"],"award-info":[{"award-number":["1R01DK132072"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["1R01DK125394"],"award-info":[{"award-number":["1R01DK125394"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["U2CDK129917\/TL1DK132769"],"award-info":[{"award-number":["U2CDK129917\/TL1DK132769"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["U2CDK129917\/TL1DK132769"],"award-info":[{"award-number":["U2CDK129917\/TL1DK132769"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Patients with CKD show bone marrow alterations, with elevated TNF\n                            <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                            and soluble urokinase plasminogen activator receptor (suPAR) levels and proinflammatory monocytic cells.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            TNF\n                            <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                            disrupted myelopoiesis, driving metabolic, transcriptional, and epigenetic changes in monocytes that increased cytokine and soluble urokinase plasminogen activator receptor production.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Secreted factors from TNF\n                            <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                            -altered myeloid cells synergistically disrupted podocyte structure and glomerular function.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune dysregulation and chronic inflammation have been implicated in the pathogenesis of CKD. Altered bone marrow hematopoiesis is commonly observed in CKD-associated conditions, such as diabetes, cardiovascular disease, and aging. However, the role of bone marrow dysfunction in CKD progression has not been thoroughly interrogated in humans. This study examines how inflammation-induced bone marrow alterations contribute to CKD progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Bone marrow aspirates were obtained from ten patients with CKD (eight with FSGS and six of whom were kidney transplant recipients) and from healthy donors. Samples were analyzed using ELISA, multiplex cytokine assays, multicolor flow cytometry, and single-cell RNA sequencing. To mimic CKD patient bone marrow alterations,\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      myelopoiesis assays were conducted under TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      exposure. Cellular and molecular changes were assessed using assay for transposase-accessible chromatin using sequencing, RNA sequencing, metabolic assays, flow cytometry, and cytokine analysis. We tested the\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      effect of TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      blockade and coinjection of TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      with IFN\n                      <jats:italic toggle=\"yes\">\u03b3<\/jats:italic>\n                      in mice. We also measured TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      levels in three different mouse models of proteinuria and in soluble urokinase plasminogen activator receptor (suPAR)\u2013deficient mice. The effect of secreted factors from TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      -driven, functionally altered myeloid cells on kidney function was evaluated using high-throughput immunofluorescence assays on cultured podocytes and filtration function assays in zebrafish.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bone marrow from patients with CKD exhibited elevated TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      and suPAR levels, along with inflammatory transcriptomic profiles in monocytic cells. TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      -driven myelopoiesis\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      induced altered monocytic cells resembling those in patients with CKD. These cells displayed increased metabolic activity, transcriptional and epigenetic reprogramming, and elevated secretion of proinflammatory cytokines and suPAR. In a cooperative manner, these secreted factors caused filtration dysfunction in zebrafish and led to cytoskeletal disarrangement in cultured podocytes. In mice, TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      exposure during myelopoiesis resulted in increased suPAR levels and proteinuria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      TNF\n                      <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                      -driven alterations in bone marrow monocytic cells contribute to glomerular dysfunction in CKD, suggesting bone marrow dysfunction as a central upstream driver of CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Podcast<\/jats:title>\n                    <jats:p>This article contains a podcast at https:\/\/dts.podtrac.com\/redirect.mp3\/www.asn-online.org\/media\/podcast\/JASN\/2025_12_02_ASN0000000828.mp3<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000828","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T16:00:32Z","timestamp":1754668832000},"page":"257-271","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-6782","authenticated-orcid":false,"given":"Ryan","family":"Spear","sequence":"first","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-0416","authenticated-orcid":false,"given":"Alexis P.","family":"Jimenez-Uribe","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7579-1042","authenticated-orcid":false,"given":"Yanxia","family":"Cao","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-1008","authenticated-orcid":false,"given":"Steve","family":"Mangos","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana G.","family":"Alcantar","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5813-4892","authenticated-orcid":false,"given":"Bong-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Psomagen Inc., Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-4680","authenticated-orcid":false,"given":"Flavio","family":"Vincenti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Surgery, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-7473","authenticated-orcid":false,"given":"Eunsil","family":"Hahm","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"10","key":"B1-20260203","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri3062","article-title":"Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response","volume":"11","author":"King","year":"2011","journal-title":"Nat Rev Immunol."},{"issue":"6","key":"B2-20260203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2006.04.008","article-title":"Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment","volume":"24","author":"Nagai","year":"2006","journal-title":"Immunity."},{"issue":"11","key":"B3-20260203","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/leu.2009.155","article-title":"The TLR1\/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate","volume":"23","author":"De Luca","year":"2009","journal-title":"Leukemia."},{"issue":"11","key":"B4-20260203","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2012-05-433755","article-title":"The function of hematopoietic stem cells is altered by both genetic and inflammatory factors in lupus mice","volume":"121","author":"Niu","year":"2013","journal-title":"Blood."},{"issue":"10","key":"B5-20260203","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.200737112","article-title":"TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80\/86+ DC capable of inducing a Th1-type response","volume":"37","author":"Sioud","year":"2007","journal-title":"Eur J Immunol."},{"issue":"4","key":"B6-20260203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2014.01.007","article-title":"Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis","volume":"14","author":"Zhao","year":"2014","journal-title":"Cell Stem Cell."},{"issue":"95","key":"B7-20260203","doi-asserted-by":"crossref","first-page":"eade3814","DOI":"10.1126\/sciimmunol.ade3814","article-title":"Heart failure promotes multimorbidity through innate immune memory","volume":"9","author":"Nakayama","year":"2024","journal-title":"Sci Immunol."},{"issue":"1","key":"B8-20260203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12933-024-02195-1","article-title":"Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34(+) hematopoietic stem cells from diabetic patients","volume":"23","author":"Vinci","year":"2024","journal-title":"Cardiovasc Diabetol."},{"issue":"1-2","key":"B9-20260203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-Dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell."},{"issue":"5","key":"B10-20260203","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1474-9726.2012.00851.x","article-title":"Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function","volume":"11","author":"Hearps","year":"2012","journal-title":"Aging Cell."},{"issue":"10","key":"B11-20260203","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","article-title":"Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities","volume":"185","author":"Li","year":"2022","journal-title":"Cell."},{"key":"B12-20260203","doi-asserted-by":"crossref","first-page":"827250","DOI":"10.3389\/fimmu.2022.827250","article-title":"Train the trainer: hematopoietic stem cell control of trained immunity","volume":"13","author":"De Zuani","year":"2022","journal-title":"Front Immunol."},{"issue":"1-2","key":"B13-20260203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell."},{"issue":"1-2","key":"B14-20260203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell."},{"issue":"9","key":"B15-20260203","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.immuni.2024.07.021","article-title":"BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity."},{"issue":"17","key":"B16-20260203","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.cell.2024.06.028","article-title":"Innate immune memory after brain injury drives inflammatory cardiac dysfunction","volume":"187","author":"Simats","year":"2024","journal-title":"Cell."},{"issue":"18","key":"B17-20260203","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","article-title":"Epigenetic memory of coronavirus infection in innate immune cells and their progenitors","volume":"186","author":"Cheong","year":"2023","journal-title":"Cell."},{"issue":"13","key":"B18-20260203","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.cell.2022.05.020","article-title":"Bone marrow hematopoiesis drives multiple sclerosis progression","volume":"185","author":"Shi","year":"2022","journal-title":"Cell."},{"issue":"12","key":"B19-20260203","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.cell.2024.04.018","article-title":"An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis","volume":"187","author":"Poscablo","year":"2024","journal-title":"Cell."},{"key":"B20-20260203","doi-asserted-by":"crossref","first-page":"3765608","DOI":"10.1155\/2016\/3765608","article-title":"Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates","volume":"2016","author":"Konigshausen","year":"2016","journal-title":"Biomed Res Int."},{"issue":"suppl 1","key":"B21-20260203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000510748","article-title":"Update on recurrent focal segmental glomerulosclerosis in kidney transplantation","volume":"144","author":"Shoji","year":"2020","journal-title":"Nephron."},{"key":"B22-20260203","doi-asserted-by":"crossref","first-page":"6499668","DOI":"10.1155\/2022\/6499668","article-title":"The role of cytokines in nephrotic syndrome","volume":"2022","author":"Ahmadian","year":"2022","journal-title":"Mediators Inflamm."},{"issue":"7","key":"B23-20260203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/CS20210625","article-title":"Mechanisms of podocyte injury and implications for diabetic nephropathy","volume":"136","author":"Barutta","year":"2022","journal-title":"Clin Sci (Lond)."},{"issue":"9","key":"B24-20260203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.21037\/atm-22-3670","article-title":"Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors","volume":"11","author":"Rashmi","year":"2023","journal-title":"Ann Transl Med."},{"issue":"8","key":"B25-20260203","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med."},{"issue":"2","key":"B26-20260203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2013.204","article-title":"Has the circulating permeability factor in primary FSGS been found?","volume":"84","author":"Jefferson","year":"2013","journal-title":"Kidney Int."},{"issue":"20","key":"B27-20260203","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med."},{"issue":"1","key":"B28-20260203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med."},{"issue":"6","key":"B29-20260203","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.3390\/ijms23063284","article-title":"The signaling pathway of TNF receptors: linking animal models of renal disease to human CKD","volume":"23","author":"Lousa","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"77","key":"B30-20260203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-015-0068-7","article-title":"Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease","volume":"16","author":"Lee","year":"2015","journal-title":"BMC Nephrol."},{"issue":"11","key":"B31-20260203","doi-asserted-by":"crossref","first-page":"e128886","DOI":"10.1172\/jci.insight.128886","article-title":"Functional methylome analysis of human diabetic kidney disease","volume":"4","author":"Park","year":"2019","journal-title":"JCI Insight."},{"issue":"7","key":"B32-20260203","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ekir.2022.03.018","article-title":"Plasma biomarkers as risk factors for incident CKD","volume":"7","author":"Sarnak","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"4","key":"B33-20260203","doi-asserted-by":"crossref","first-page":"e0266854","DOI":"10.1371\/journal.pone.0266854","article-title":"Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus","volume":"17","author":"Wu","year":"2022","journal-title":"PLoS One."},{"issue":"3","key":"B34-20260203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","article-title":"TNF-alpha coordinates hematopoietic stem cell survival and myeloid regeneration","volume":"25","author":"Yamashita","year":"2019","journal-title":"Cell Stem Cell."},{"issue":"4","key":"B35-20260203","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.2015.162","article-title":"Macrophage-derived tumor necrosis factor-\u03b1 mediates diabetic renal injury","volume":"88","author":"Awad","year":"2015","journal-title":"Kidney Int."},{"issue":"12","key":"B36-20260203","doi-asserted-by":"crossref","first-page":"e22206","DOI":"10.1096\/fj.202200923R","article-title":"Podocyte derived TNF-\u03b1 mediates monocyte differentiation and contributes to glomerular injury","volume":"36","author":"Nishad","year":"2022","journal-title":"FASEB J."},{"key":"B37-20260203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-213X-10-76","article-title":"A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development","volume":"10","author":"Xie","year":"2010","journal-title":"BMC Dev Biol."},{"issue":"5","key":"B38-20260203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/zeb.2015.1093","article-title":"A fluorescence-based assay for proteinuria screening in larval zebrafish (Danio Rerio)","volume":"12","author":"Hanke","year":"2015","journal-title":"Zebrafish."},{"issue":"1","key":"B39-20260203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med."},{"issue":"18","key":"B40-20260203","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2012-05-432906","article-title":"Interferon-\u03b3 impairs proliferation of hematopoietic stem cells in mice","volume":"121","author":"de Bruin","year":"2013","journal-title":"Blood."},{"issue":"1","key":"B41-20260203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41420-020-00354-3","article-title":"Induction of differentiation of the acute myeloid leukemia cell line (HL-60) by a securinine dimer","volume":"6","author":"Hou","year":"2020","journal-title":"Cell Death Discov."},{"issue":"4","key":"B42-20260203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/imcb.12015","article-title":"The influence of agents differentiating HL-60 cells toward granulocyte-like cells on their ability to release neutrophil extracellular traps","volume":"96","author":"Manda-Handzlik","year":"2018","journal-title":"Immunol Cell Biol."},{"issue":"6204","key":"B43-20260203","doi-asserted-by":"crossref","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science."},{"key":"B44-20260203","doi-asserted-by":"crossref","first-page":"116570","DOI":"10.1016\/j.lfs.2019.116570","article-title":"Klotho restrain RIG-1\/NF-\u03baB signaling activation and monocyte inflammatory factor release under uremic condition","volume":"231","author":"He","year":"2019","journal-title":"Life Sci."},{"issue":"4","key":"B45-20260203","doi-asserted-by":"crossref","first-page":"e13792","DOI":"10.1111\/acel.13792","article-title":"Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammaging","volume":"22","author":"Karakaslar","year":"2023","journal-title":"Aging Cell."},{"issue":"18","key":"B46-20260203","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.emboj.7601824","article-title":"The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation","volume":"26","author":"Feinberg","year":"2007","journal-title":"EMBO J."},{"issue":"6204","key":"B47-20260203","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science."},{"key":"B48-20260203","doi-asserted-by":"crossref","first-page":"935536","DOI":"10.3389\/fphar.2022.935536","article-title":"Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol."},{"key":"B49-20260203","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fgene.2018.00394","article-title":"Reciprocal regulation of metabolic reprogramming and epigenetic modifications in cancer","volume":"9","author":"Yu","year":"2018","journal-title":"Front Genet."},{"issue":"23","key":"B50-20260203","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1242\/dev.125.23.4655","article-title":"Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function","volume":"125","author":"Drummond","year":"1998","journal-title":"Development."},{"issue":"2","key":"B51-20260203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2004090754","article-title":"Kidney development and disease in the zebrafish","volume":"16","author":"Drummond","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B52-20260203","doi-asserted-by":"crossref","first-page":"658270","DOI":"10.1155\/2013\/658270","article-title":"\u201cZebrafishing\u201d for novel genes relevant to the glomerular filtration barrier","volume":"2013","author":"Hanke","year":"2013","journal-title":"Biomed Res Int."},{"issue":"3","key":"B53-20260203","doi-asserted-by":"crossref","first-page":"bio040253","DOI":"10.1242\/bio.040253","article-title":"Mutation of microphthalmia-associated transcription factor (mitf) in zebrafish sensitizes for glomerulopathy","volume":"8","author":"Muller-Deile","year":"2019","journal-title":"Biol Open."},{"issue":"6","key":"B54-20260203","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"issue":"12","key":"B55-20260203","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B56-20260203","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol."},{"issue":"2","key":"B57-20260203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7150\/ijbs.15659","article-title":"Increase in peripheral blood intermediate monocytes is associated with the development of recent-onset type 1 diabetes mellitus in children","volume":"13","author":"Ren","year":"2017","journal-title":"Int J Biol Sci."},{"issue":"9","key":"B58-20260203","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/apm.12419","article-title":"Elevated levels of peripheral blood CD14(bright) CD16+ and CD14(dim) CD16+ monocytes may contribute to the development of retinopathy in patients with juvenile onset type 1 diabetes","volume":"123","author":"Ryba-Stanislawowska","year":"2015","journal-title":"APMIS."},{"issue":"1","key":"B59-20260203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-016-1216-6","article-title":"CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis","volume":"19","author":"Tsukamoto","year":"2017","journal-title":"Arthritis Res Ther."},{"issue":"11","key":"B60-20260203","first-page":"e146215","article-title":"Higher circulating intermediate monocytes are associated with cognitive function in women with HIV","volume":"6","author":"Veenhuis","year":"2021","journal-title":"JCI Insight."},{"issue":"1","key":"B61-20260203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13075-023-03178-5","article-title":"Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment","volume":"25","author":"Li","year":"2023","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"B62-20260203","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"B63-20260203","doi-asserted-by":"crossref","first-page":"F515","DOI":"10.1152\/ajprenal.00533.2012","article-title":"TNF-\u03b1 mediates increased susceptibility to ischemic AKI in diabetes","volume":"304","author":"Gao","year":"2013","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B64-20260203","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int."},{"issue":"1","key":"B65-20260203","doi-asserted-by":"crossref","first-page":"23587","DOI":"10.1038\/s41598-021-02864-1","article-title":"Effects of tumor necrosis factor-\u03b1 inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy","volume":"11","author":"Taguchi","year":"2021","journal-title":"Sci Rep."},{"issue":"4","key":"B66-20260203","doi-asserted-by":"crossref","first-page":"e246822","DOI":"10.1001\/jamanetworkopen.2024.6822","article-title":"Kovesdy, CP: anti-tumor necrosis factor therapy and risk of kidney function decline and mortality in inflammatory bowel disease","volume":"7","author":"Sumida","year":"2024","journal-title":"JAMA Netw Open."},{"issue":"12","key":"B67-20260203","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1007\/s10067-022-06330-9","article-title":"The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study","volume":"41","author":"Swart","year":"2022","journal-title":"Clin Rheumatol."},{"key":"B68-20260203","doi-asserted-by":"crossref","first-page":"746396","DOI":"10.3389\/fphar.2021.746396","article-title":"Risk of adverse events after Anti-TNF treatment for inflammatory rheumatological disease. A meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol."},{"issue":"suppl 1","key":"B69-20260203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin Drug Saf."},{"issue":"25","key":"B70-20260203","doi-asserted-by":"crossref","first-page":"e2215711120","DOI":"10.1073\/pnas.2215711120","article-title":"In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy","volume":"120","author":"Guimaraes","year":"2023","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:45:27Z","timestamp":1786131927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000828","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"2024-12-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}